The company anticipates it will respond to the FDA AIR with supplemental data in Q1 2025. The company is seeking to obtain regulatory clearance to conduct clinical trials in India with strategic partner Shalby Hospitals. The company anticipates shipping a robot to India to initiate clinical trial training by January 2025. The company is seeking to obtain FDA clearance for the mBos TKA System. Continue exploring domestic relationships. Seek to continue expanding international relationships.
Education
About Us
Working with TipRanks
Follow Us
1